Genenta Science (NASDAQ:GNTA) Stock Price Breaks Above 50-Day Moving Average – Should You Sell?

Genenta Science S.p.A. Unsponsored ADR (NASDAQ:GNTA)’s stock price passed above its 50-day moving average during trading on Monday. The stock has a 50-day moving average of $0.78 and traded as high as $0.87. Genenta Science shares last traded at $0.8166, with a volume of 1,569,047 shares changing hands.

Wall Street Analyst Weigh In

Separately, Weiss Ratings downgraded Genenta Science from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, October 28th. One equities research analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, Genenta Science currently has an average rating of “Sell”.

Genenta Science Stock Up 32.1%

The business’s 50 day moving average is $0.78 and its 200-day moving average is $1.04.

About Genenta Science

Genenta Science S.p.A. is a biotechnology company focused on developing cell-based gene therapies for cancer. The company’s approach is designed to use a patient’s own hematopoietic stem cells, modified outside the body, to deliver therapeutic proteins directly within the tumor microenvironment.

Genenta’s lead platform, TEMFERON, uses genetically engineered stem cells to produce interferon alpha in tumors. This strategy is intended to concentrate treatment at the disease site while limiting the systemic toxicity associated with administering interferon alpha throughout the body.